Related Experiment Video
Updated: Jun 6, 2025

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types
Vijaykumar R Holla1, Michael P Kahle1, Sun-Hee Kim1
1Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, Houston, TX.
Purpose:
PD-1 inhibition is effective in patients with mismatch repair deficient (dMMR) solid tumors in a tumor-agnostic fashion. However, dMMR testing by immunohistochemistry (IHC) is not routinely performed across tumor types. By contrast, next-generation sequencing (NGS) for somatic genomic alterations is frequently performed across tumor types. We hypothesized that NGS would identify patients with alterations in mismatch repair (MMR) genes and that these patients would have higher rates of MMR protein loss by IHC. This would support the utility of IHC reflex testing after NGS and potential matching to approved therapeutic options.
Methods:
From January 2016 to December 2021, 15,701 patients with solid tumors received NGS covering the MMR genes, and 4,994 patients had both IHC and NGS. Sequencing results were analyzed for mutations in MMR genes, tumor type distribution, and concordance with IHC results when available.
Results:
Six hundred and ninety-eight (4.4%) of 15,701 patients had mutations in one of the MMR genes. Mutations were found across tumor types. Three hundred and seventeen (6.3%) of 4,994 patients displayed IHC loss for at least one MMR protein. 33.8% patients (110/325) patients with MMR mutations had dMMR, compared with just 4.4% (207/4,669) patients without mutations (P < .001); dMMR rate varied by mutation type.
Conclusion:
Mutations in MMR genes are found in multiple tumor types where IHC testing is not routine. Reflex IHC testing of patients carrying MMR gene mutations, especially those known or inferred to be inactivating, may identify more patients with dMMR and matched treatment options. However, dedicated IHC screening is needed to capture majority of the patients.
Insights
Next-generation sequencing (NGS) can identify mismatch repair (MMR) gene mutations in solid tumors, indicating potential for MMR protein loss. This supports using NGS to guide immunohistochemistry (IHC) testing for dMMR patients.
Area of Science:
- Oncology
- Genomics
- Cancer Biomarkers
Background:
- Mismatch repair deficient (dMMR) solid tumors respond to PD-1 inhibition.
- Immunohistochemistry (IHC) for dMMR is not universally applied.
- Next-generation sequencing (NGS) for genomic alterations is common.
Purpose of the Study:
- To determine if NGS can identify patients with mismatch repair (MMR) gene alterations.
- To assess the correlation between NGS-identified MMR gene mutations and MMR protein loss by IHC.
- To support reflex IHC testing after NGS for dMMR identification.
Main Methods:
- Analysis of 15,701 solid tumor patients undergoing NGS for MMR genes (2016-2021).
- Comparison of NGS results with IHC data for 4,994 patients.
- Evaluation of mutation types and tumor distribution.
Main Results:
- MMR gene mutations were identified in 4.4% of patients across various tumor types.
- 33.8% of patients with MMR mutations showed MMR protein loss by IHC, versus 4.4% without mutations.
- IHC loss varied based on specific MMR gene mutation type.
Conclusions:
- NGS can detect MMR gene mutations in diverse tumor types lacking routine IHC.
- Reflex IHC testing post-NGS may increase dMMR patient identification for targeted therapies.
- Dedicated IHC screening remains essential for comprehensive dMMR detection.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
09:29Author Spotlight: Decoding DNA Repair by Extrachromosomal NHEJ Assay and HR Assays
Published on: February 2, 2024
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Base Excision Repair
The first step of...
Overview of DNA Repair
Chemically...
Cancers Originate from Somatic Mutations in a Single Cell
Genome Copying Errors